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a b s t r a c t
Stem cells are capable of both self-renewal (proliferation) and differentiation. Determining the
regulatory mechanisms controlling the balance between stem cell proliferation and differentiation is
not only an important biological question, but also holds the key for using stem cells as therapeutic
agents. The Caenorhabditis elegans germ line has emerged as a valuable model to study the molecular
mechanisms controlling stem cell behavior. In this study, we describe a large-scale RNAi screen that
identiﬁed kin-10, which encodes the β subunit of protein kinase CK2, as a novel factor regulating stem
cell proliferation in the C. elegans germ line. While a loss of kin-10 in an otherwise wild-type background
results in a decrease in the number of proliferative cells, loss of kin-10 in sensitized genetic backgrounds
results in a germline tumor. Therefore, kin-10 is not only necessary for robust proliferation, it also
inhibits the proliferative fate. We found that kin-10’s regulatory role in inhibiting the proliferative fate is
carried out through the CK2 holoenzyme, rather than through a holoenzyme-independent function, and
that it functions downstream of GLP-1/Notch signaling. We propose that a loss of kin-10 leads to a defect
in CK2 phosphorylation of its downstream targets, resulting in abnormal activity of target protein(s) that
are involved in the proliferative fate vs. differentiation decision. This eventually causes a shift towards
the proliferative fate in the stem cell fate decision.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Stem cells are capable of both self-renewal (proliferating to
produce daughter cells similar to the parental cell) and differentia-
tion (producing daughter cells with specialized cellular functions).
They reside in most, if not all, tissues in the human body and
function to maintain tissue homeostasis (Lanza et al., 2004; Lazzeri
et al., 2012). The activities of stem cell proliferation and differentia-
tion must be tightly controlled in a complex biological context.
Excessive proliferation can lead to tumor formation, with aberrant
stem cell self-renewal possibly contributing to cancer development
(Antoniou et al., 2013; Baylin, 2009; Reya et al., 2001). In contrast,
uncontrolled differentiation can deplete the stem cell pool, and
ultimately lead to tissue atrophy or the loss of tissue function
(Rando, 2006; Silva and Conboy, 2008).
The C. elegans germ line has emerged as a powerful system to
study how the balance between stem cell proliferation and differ-
entiation is maintained (Hansen and Schedl, 2013; Hubbard, 2007;
Joshi et al., 2010). The C. elegans hermaphrodite contains two gonad
arms that meet at a common uterus. Each gonad consists of a blind-
ended U-shaped tube, with the distal end being furthest from the
uterus (Hirsh et al., 1976) (Fig. 1A). Along the distal-proximal axis
the germ cells in a given region exhibit a distinct cellular morphol-
ogy, with proliferative germ cells located at the distal portion of the
gonad, close to the tip, and differentiating germ cells residing
more proximally (Hirsh et al., 1976; Kimble and White, 1981)
(Fig. 1B). In adult animals, proliferative cells form a population of
200–250 germ cells, referred to as the proliferative or mitotic
zone (MZ) (Lamont et al., 2004). Cells within the MZ mitotically
divide, maintaining a population of mitotic cells in this region. Germ
cell differentiation occurs as cells move proximally, away from the
distal tip. Differentiating cells progressively undergo various stages
of meiosis, eventually forming fully differentiated gametes (Fig. 1B).
Cells within the MZ remain proliferative due to their close
proximity to the Distal Tip Cell (DTC), which provides the pro-
liferation promoting signal, primarily through the Notch signaling
pathway (Austin and Kimble, 1987; Kimble and White, 1981)
(Fig. 1B and C). A single DTC caps the distal end of each gonad
arm and expresses the Notch DSL ligand, LAG-2 (Henderson et al.,
1994; Tax et al., 1994), while germ cells express the receptor, GLP-
1, on their cellular surface (Crittenden et al., 1994; Yochem and
Greenwald, 1989). Interaction between the DTC and germ cells is
thought to lead to the activation of the Notch signaling cascade,
resulting in the activation of downstream gene transcription
necessary for determining and maintaining the proliferative fate
of the germ cells (Austin and Kimble, 1987; Berry et al., 1997;
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Crittenden et al., 1994; Kimble and White, 1981). It is believed that
once germ cells move away from DTC, Notch signaling strength
decreases (Berry et al., 1997), leading to cells differentiating by
entering into meiotic prophase, eventually developing into either
sperm or oocytes. Mutations that cause increased GLP-1/Notch
signaling result in animals whose germ lines are over-proliferative
in that they have an increased number of mitotically dividing cells
as compared to wild-type animals (Berry et al., 1997; Pepper
et al., 2003).
The GLP-1/Notch signaling pathway promotes the proliferative
fate, at least in part, by promoting the activities of FBF-1 and FBF-2
(Fig. 1C). FBF-1 and FBF-2 are two nearly identical RNA-binding
proteins (RBPs) of the PUF family (Pumilio and FBF), and are often
collectively referred to as FBF (Crittenden et al., 2002; Lamont et
al., 2004). FBF inhibits two redundant RNA regulatory pathways,
the GLD-1 and GLD-2 pathways, which function genetically down-
stream of GLP-1/Notch signaling to promote meiotic entry and/or
inhibit proliferation (Francis et al., 1995b; Kadyk and Kimble, 1998)
(Fig. 1C). The activity of either the GLD-1 pathway or the GLD-2
pathway alone are sufﬁcient to mediate the transition into meiotic
differentiation (Francis et al., 1995b; Kadyk and Kimble, 1998);
however, when the activities of both pathways are signiﬁcantly
reduced or eliminated, meiotic entry is severely compromised,
resulting in many proliferative germ cells failing to transit into
meiotic prophase, but rather continue to proliferate forming a
germline tumor (Eckmann et al., 2004; Hansen et al., 2004a,
2004b; Kadyk and Kimble, 1998).
GLD-1 is a member of the STAR/KH family of proteins that
includes mammalian QUAKING and SAM68 (Jan et al., 1999; Jones
et al., 1996; Jones and Schedl, 1995), whereas NOS-3, which also
functions in the GLD-1 pathway, shows similarity to the Drosophila
translational regulator NANOS (Hansen et al., 2004b; Kraemer
et al., 1999). GLD-1 is predicted to promote the proliferation-to-
differentiation transition, in part, by translationally repressing
mRNAs required for proliferation (Lee and Schedl, 2001;
Scheckel et al., 2012). In gld-1(null) single mutants, the prolifera-
tive fate vs. differentiation decision occurs properly in that
proliferative cells enter meiosis properly as they leave the MZ.
However, these meiotic cells fail to properly progress through
meiotic prophase and instead re-enter the mitotic cell cycle,
resulting in a population of proliferative cells in the proximal
end of the gonad (referred to as a Proximal or Pro tumor) (Francis
et al., 1995a). gld-2 encodes the catalytic portion of a poly
(A) polymerase (PAP), albeit without a recognizable RNA-binding
domain, while gld-3, which is also found in the GLD-2 pathway,
encodes a KH-domain RBP, similar to Drosophila Bicaudal-C
(Eckmann et al., 2004; Wang et al., 2002). GLD-2 and GLD-3 are
thought to function in a complex, with GLD-3 providing RNA-
binding speciﬁcity (Eckmann et al., 2004; Wang et al., 2002). It is
postulated that GLD-2/GLD-3 control the switch from proliferation
to differentiation, in part, by stabilizing or increasing the rate of
translation of target mRNAs that promote entry into meiosis
(Eckmann et al., 2004; Wang et al., 2002). A third redundant
pathway, parallel to the GLD-1 and the GLD-2 pathways, has been
proposed based on the observation that meiotic entry still occurs
when key components from both the GLD-1 and the GLD-2
pathways are eliminated. These animals have excess proliferation
in the distal end of the gonad, resulting in the MZ being larger
than normal, as well as proliferative cells in the proximal end of
the gonad (Pro tumor). However, components of the third pathway
are still yet to be determined (Hansen et al., 2004a).
The genes described above form the core genetic pathway that
regulates the proliferative fate vs. differentiation decision in the C.
elegans germ line. However, many other factors have been identi-
ﬁed that interact with this core pathway. These factors are
involved in a range of different cellular processes including RNA
processing and regulation (Bukhari et al., 2012; Kerins et al., 2010;
Killian and Hubbard, 2004; Mantina et al., 2009; Racher and
Hansen, 2012; Wang et al., 2012), protein degradation (Burger
et al., 2013; Macdonald et al., 2008), and other functions (Bessler
et al., 2007; Dorsett et al., 2009; Lee et al., 2006). Many of these
factors appear to act as modulators that ﬁne-tune the activity
of the core pathway. With the potential redundancy and complex-
ity of this regulatory network, there are likely many other
factors involved. Particularly, post-translational regulation through
Fig. 1. Caenorhabditis elegans hermaphrodite germ line and the proliferative fate vs.
differentiation regulatory pathway: (A) a DIC image of a hermaphrodite gonad.
The hermaphrodite gonad is in the shape of a blind-ended U-shaped tube
(outlined). Asterisk marks the distal end of the gonad. Scale bar¼50 μm.
(B) Different cellular morphology can easily be distinguished when the gonad is
dissected out of the animal body and stained, in this case, with DAPI. The gonad has
a distal to proximal polarity. Proliferative germ cells are located at the distal end of
the gonad while differentiated gametes are at the proximal end (seen as oocytes
and sperm). The transition zone marks the region where meiotic entry is ﬁrst
visible. Asterisk marks the distal end of the gonad. Scale bar¼50 μm. (C) The core
regulatory pathway controlling the germline proliferative fate vs. differentiation
decision is shown with genes promoting the proliferative fate in green and those
promoting meiotic entry (differentiation) in red. The canonical GLP-1/Notch
signaling pathway (LAG-2, GLP-1, LAG-1/SEL-8) promotes proliferation. The FBF/
FOG-1 RNA regulatory pathway relays the proliferative cue within germ cells to
maintain the proliferative fate. The GLD-1 pathway (GLD-1, NOS-3) and GLD-2
pathway (GLD-2, GLD-3) function redundantly to inhibit the proliferative fate and/
or promote meiotic entry. A third parallel pathway has been hypothesized, but no
conﬁrmed members have been identiﬁed. (D) A diagram illustrating CK2 composi-
tion. Protein kinase CK2 is composed of two α subunits and two β subunits,
appearing in a butterﬂy conformation. The α subunits are the catalytic subunits and
possess the kinase activity. The β subunits are the regulatory subunits and have
been proposed to enhance the stability, activity and speciﬁcity of the α subunits. In
C. elegans, the α subunit is encoded by kin-3 and the β subunit is encoded by kin-10
(Hu and Rubin, 1990, 1991).
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protein phosphorylation has also been identiﬁed as being
involved, such as CYE-1/CDK-2 phosphorylation on GLD-1 (Fox
et al., 2011; Jeong et al., 2011) and MAP kinase (MPK-1) phosphor-
ylation on NOS-3 (Arur et al., 2011). Indeed, phosphorylation by
many kinases, including MAPK, PKA, Polo kinase and protein
kinase CK2, has been implicated in the control of proliferation in
other systems (Gabriel and Litchﬁeld, 2013; Morrison, 2012; Pezuk
et al., 2013; Yu et al., 2013).
Protein kinase CK2 (also known as casein kinase 2) is a highly
conserved protein kinase and is believed to be present in all
eukaryotes (Alvarez et al., 2013) (Figs. 1D and 2A). It is typically
found in a tetrameric complex consisting of two catalytic subunits
(α and/or α0 in humans) and two regulatory subunits (β subunits)
(Hathaway and Traugh, 1979; Thornburg and Lindell, 1977)
(Fig. 1D). The catalytic subunit is the enzymatic core, and the
regulatory subunit is believed to enhance the stability, activity and
speciﬁcity of the catalytic subunit (Bibby and Litchﬁeld, 2005). CK2
has been recognized as a pleiotropic and ubiquitous kinase with
over 300 proteins either identiﬁed or predicted to be phosphory-
lated by CK2, and this list is steadily growing (Cesaro and Salvi,
2013; Meggio and Pinna, 2003).
In mammals, CK2 is associated with a variety of important
cellular processes, including cell viability, cell cycle progression
and apoptosis (Guerra and Issinger, 1999; Litchﬁeld, 2003). Ele-
vated CK2 activity has also been detected in various human
cancers (Daya-Makin et al., 1994; Faust et al., 2000; Landesman-
Bollag et al., 1998; Stalter et al., 1994; Yenice et al., 1994). More-
over, CK2 has been directly implicated in tumor formation in
transgenic mice with over-expression of CK2 leading to lympho-
magenesis and mammary tumors (Landesman-Bollag et al., 2001;
Seldin and Leder, 1995). Thus, CK2 has been proposed to be a
therapeutic target for cancer treatment and chemical inhibitors
targeting CK2 have been subjected to clinical trials in recent years
(Battistutta et al., 2011; Trembley et al., 2010).
Here, we report the characterization of protein kinase CK2 as a
new member of the pathway controlling the balance between the
proliferative fate and differentiation in the C. elegans germ line.
We ﬁnd that CK2 is not only needed for robust germline prolifera-
tion, but also functions in the GLD-1 pathway, downstream of
GLP-1/Notch signaling, to promote meiotic entry and/or inhibit the
proliferative fate. A reduction of CK2 activity reduces germline
proliferation; however, in genetic backgrounds with elevated
GLP-1/Notch signaling, excess proliferation is observed, suggesting
that CK2 normally inhibits the proliferative fate and/or promotes
differentiation. Mosaic analysis suggests that CK2’s function to
regulate the proliferative fate resides in the germ line rather than
Fig. 2. kin-10 is identiﬁed from a genome-wide RNAi screen: (A) protein alignment of the CK2β subunit from different species. KIN-10 (CK2β) is highly conserved with 70%
amino acid identity between KIN-10 and the corresponding human ortholog. Dots represent identical amino acid residues. Accession numbers for proteins used in alignment
are: NP_001311 (human), NP_001005081 (frog), NP_996415 (ﬂy), NP_492254 (worm), and NP_014682 (yeast). (B) Candidate genes identiﬁed from the genome-wide RNAi
screen. Most of the genes identiﬁed from the screen show highly penetrant formation of over-proliferation in the rrf-1(pk1417); gld-3(q730) double mutant background.
pL4440 is the vector-only negative control. ‘Tumorous’ animals have excess proliferative cells in the germ line (may be in the distal and/or proximal (Pro) arm). Number of
animals counted: pL4440, n¼404; nos-3, n¼268; C27F2.10, n¼115; lsm-4, n¼220; mog-3, n¼273; kin-10, n¼258; Y65B4A.1, n¼84; tftc-3, n¼427. Error bar¼standard
deviation. (C) kin-10 gene model and the ok1751 mutation. This study uses the kin-10(ok1751) allele, which is a 1452 bp deletion (also contains 1 bp insertion), spanning
almost the entire length of the kin-10 coding region. As conﬁrmed by western blot using antibodies speciﬁcally against KIN-10, kin-10(ok1751) is a null allele (Fig. S2A).
Dashed lines mark the positions of the tm1283 and the ok1751 mutations. Black bars represent the coding region. Gray bars represent predicted 50 and 30UTRs.
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the somatic gonad. Therefore, as a protein kinase, it is likely
through regulating the activity of downstream targets that CK2
helps to maintain a proper balance between proliferation and
differentiation in the C. elegans germ line.
Materials and methods
General methods and nematode strains
C. elegans handling, genetic manipulation and maintenance was
performed using standard methods (Brenner, 1974). Experiments were
performed at 20 1C unless otherwise stated. Animals used for experi-
ments were prepared by L1 synchronization unless otherwise stated.
Brieﬂy, mixed stage hermaphrodites (gravid adults, larvae and eggs)
were bleached (0.8 g NaOH, 8 ml sodium hypochlorite, 30 ml H2O) for
3–5min with vigorous shaking to isolate eggs, which were then
allowed to hatch in 1 phosphate buffered saline (PBS) at 20 1C for
24 h to arrest animals at the L1 stage. Arrested animals were washed
with 1 PBS and placed on plates (NGM or RNAi) to develop to
speciﬁc stages for analysis.
The following alleles were used in this study - LGI: gld-2(q497),
rrf-1(pk1417), gld-1(q485), kin-10(ok1751), kin-3(ok1516); LGII: fbf-1
(ok91), fbf-2(q704), gld-3(q730), nos-3(oz231); LGIII: glp-1(q175),
glp-1(ar202gf), glp-1(oz264gf), lin-12(n302gf). For kin-10(ok1751),
the genetic mutant was out-crossed against wild-type (N2) three
times before being used in the study.
RNA interference
RNAi was performed by feeding. RNAi plates (standard NGM plates
containing 25 μg/ml carbenicillin and 0.2% β-lactose) were seeded
with an overnight culture of bacteria containing an RNAi clone speciﬁc
to the gene of interest and grown for two days to establish a bacterial
lawn. For the genome-wide RNAi screen, RNAi bacteria were obtained
from the Ahringer RNAi library (Kamath et al., 2003). L4 stage rrf-1
(pk1417); gld-3(q730)/mIn1[mIs14 dpy-10(e128)] animals were placed
on the plates, and allowed to develop at 22 1C. Their progeny (the F1
generation) were analyzed for phenotypes as young adults (1 day past
L4 stage). The screen consisted of two stages. For the primary screen,
as it was intended to screen the majority of genes in the genome in a
timely fashion, animals were screened using a ﬂuorescent dissection
microscope and non-GFP animals were screened for excess germline
proliferation by visual examination on a dissecting microscope (large
regions of excess proliferation can be visualized under a dissecting
microscope as clear patches in the gonad displacing more yellowish
yolk containing developing oocytes). A secondary screen was then
performed to verify the potential positives identiﬁed in the primary
screen by repeating the RNAi and analyzing the animals by DIC
microscopy, as well as by gonad dissection and staining using α-
REC-8 and α-HIM-3 antibodies (Hansen et al., 2004a; Pasierbek et al.,
2001; Zetka et al., 1999). For determining the CK2 holoenzyme vs. KIN-
10 independent functions, RNAi bacteria for kin-3 or kin-10 were
constructed using the wild-type kin-3 or kin-10 cDNA, respectively.
The kin-10 construct was made to verify the results obtained with the
kin-10 clone contained in the library. The primers used for kin-3(RNAi)
vector pDH217 were R55 (TGCCTCCGATTCCTAGCC) and R56
(AGCGCCGTCAATTTTGGCAT). The primers used for kin-10(RNAi) vector
pDH216were R78 (AGAGACCATAATTATTGAATTGTCC) and R79 (TGAG-
TAGTTCGGAGGAGGT). PCR ampliﬁed products were then cloned into a
T-tailed pL4440 vector (see Leahul, 2011 for information on T-tailing),
veriﬁed by sequencing and transformed into the HT115(DE3) bacteria
(Timmons and Fire, 1998).
Generation of α-KIN-10 antibodies
The antigen used to generate α-KIN-10 antibodies was generated
by amplifying the kin-10 wild-type cDNA using primers T43 and T44
and the product was cloned into pET-29a(þ) vector (Novagen) with
EcoRI and HindIII sites to create an N-terminal S-tagged KIN-10
(full-length) protein (N-S-KIN-10). Clones were veriﬁed by sequencing
and transformed into BL21(DE3) bacteria for protein expression.
The N-S-KIN-10 protein was expressed and puriﬁed using the
S-tag following the manufacturer’s instructions (Novagen). Puriﬁed
N-S-KIN-10 protein fractions were concentrated using a 10K Centricon
ﬁlter (Millipore), mixed with keyhole limpet hemocyanin (KLH) and
injected into Sprague Dawley rats. To afﬁnity purify the α-KIN-10
antibodies from crude serum, an N-terminal GST-tagged version of the
recombinant protein was constructed with kin-10 wild-type cDNA
using primers T75 and T76, and EcoRI and XhoI sites (pGEX-4T-3
vector; GE Healthcare). The α-KIN-10 antibodies were then afﬁnity
puriﬁed on blot strips (Harlow and Lane, 1988).
T43 – TTTTTTGAATTCAGTAGTTCGGAGGAGGTATC
T44 – TTTTTTAAGCTTTCAGAGACCATAATTATTGAATTG
T75 – TTTTTTGAATTCCAGTAGTTCGGAGGAGGTATC
T76 – TTTTTTCTCGAGTCAGAGACCATAATTATTGAATTG
Gonad dissection, immunostaining and imaging
Gonad dissection and antibody staining were performed as
previously described (Jones et al., 1996). Brieﬂy, dissected gonads
were ﬁxed with 3% paraformaldehyde in 0.1 M KPO4 (pH 7.2), for
10 min at room temperature followed by a postﬁx and permeabi-
lization with ice-cold 100% methanol overnight at 20 1C. Gonads
were then blocked with 30% goat serum in 1 PBT (1 PBS with
0.1% Tween-20) at room temperature for 1 h then incubated in 30%
goat serum (in 1 PBT) containing the corresponding 11 anti-
bodies overnight at 4 1C. 11 antibodies used were: α-REC-8
(Pasierbek et al., 2001) at 1:200, α-HIM-3 (Zetka et al., 1999) at
1:500, α-phos-H3 (Cell Signaling Solutions) at 1:400, α-Nop1p
(EnCor Biotech) at 1:200, α-SYN-4 (Jantsch-Plunger and Glotzer,
1999) at 1:400, α-GLD-1 (Jones et al., 1996) at 1:100, and α-KIN-10
(this study) at 1:200. Nuclear DNA was visualized by DAPI
(40,6-diamidino-2-phenylindole). For whole mount immunostain-
ing, late L4 and young adult animals were washed off bacteria and
dropped onto a poly-lysine coated microscope slide (Sigma, Cat.
no. P0425). Animals were freeze-cracked following procedures
described in Duerr (2006), followed by ﬁxation on the slide using
cold 3% paraformaldehyde in 0.1 M KPO4 (pH 7.2) for 10 min on
ice. Animals not attached to the slide were then washed off the
slide with 1 PBT into a small glass tube and processed in-tube
afterwards following the same procedures for dissected gonads
(above). All images presented were obtained from animals pro-
cessed in-tube. For DAPI staining of whole mount animals, animals
were washed off plates using 1 PBS, washed two times to
remove residual bacterial and subsequently ﬁxed at room tem-
perature with 3% formaldehyde in 0.1 M KPO4 (pH 7.2) for 1 h,
followed by a postﬁx and permeabilization with ice-cold 100%
methanol at 20 1C for 48 h. Animals were then washed with 1
PBT and stained with DAPI. Both DIC and ﬂuorescent images were
captured using a Zeiss Imager Z.1 microscope with an AxioCam
MRm camera (Zeiss). Adobe Photoshop CS5 was used for image
assembly and NIH ImageJ was used for germ cell counting and
intensity measurement.
Western blot
Protein samples were prepared by boiling 100–150 young adult
hermaphrodites in 20 μl Sample buffer (50 mM Tris–HCl pH 6.8,
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2% SDS, 10% glycerol, 1% β-mercaptoethanol and 0.02% bromophe-
nol blue). Proteins were resolved on a 12.5% SDS-PAGE gel and
transferred to nitrocellulose membrane using Mini-Trans Blot Cell
(Bio-Rad). The membrane was blocked with 5% Carnation milk in
1 TBS (137 mM NaCl, 25 mM Tris–HCl, pH 7.2, 2.5 mM KCl), and
incubated overnight at 4 1C with 11 antibodies of either afﬁnity
puriﬁed α-KIN-10 (1:500) or α-paramyosin (MH16, hybridoma cell
line from Developmental Studies Hybridoma Bank) tissue culture
supernatant. The membrane was then washed with 1 TBST
(1 TBS with 0.05% Tween-20), and incubated with correspond-
ing HRP-conjugated 21 antibodies (1:3000; Jackson Laboratories)
for 2 h at room temperature. Signals were visualized using Super-
Signal WestPico substrate (Thermo Scientiﬁc, Waltham, MA), and
exposed to Kodak (Rochester, NY) BioMax MR ﬁlms.
Extrachromosomal array
The kin-10 extrachromosomal array ugEx27 contains a FLAG-
tagged kin-10 construct (pDH181). pDH181 was generated by
inserting a 1 FLAG tag (DYKDDDDK), along with a KOZAK
ribosomal binding site (gccaccatg), an AvrII site and a BamHI site
(oligos T59 and T61) into pBluescript II KS (þ) (Stratagene) using
the XbaI and PstI sites. The kin-10 wild-type genomic fragment,
including its predicted 30UTR (742 bp downstream of the stop
codon), was ampliﬁed (primers T56 and T57) from wild-type (N2)
DNA and sub-cloned into the vector using the SacI and the AvrII
sites. Next, the BamHI and HindIII sites were used to sub-clone the
predicted 50UTR (263 bp upstream of the start codon), in front of
the KOZAK-FLAG tag, while also introducing an XhoI site (primers
T54 and T55). Since kin-10 is predicted to be in an operon, the
operon promoter, a 1239 bp sequence from the start of npp-2 to
the upstream gene mei-1, was ampliﬁed using primers T10 and
T11, and sub-cloned into the construct using the XhoI and the KpnI
sites, resulting in the completed pDH181 construct. The construct
sequence was veriﬁed by sequencing.
The FLAG-tag kin-10 construct (pDH181) was injected (at 15 ng/ml)
into kin-10(ok1751)/hT2g[bli-4(e937) let-?(q782) qIs48] hermaphrodite
gonads, together with pCFJ90 (Pmyo-2::mCherry) and pGH8 (Prab-3::
mCherry) plasmid as visible transformation co-injection markers.
Presence of the FLAG-tag kin-10 construct was veriﬁed by PCR and
western blot with the α-KIN-10 antibodies (this study) and the α-FLAG
antibodies (1:1000, Sigma). The extrachromosomal array was main-
tained in the kin-10(ok1751) homozygous background as XB632
(kin-10(ok1751); ugEx27[kin-10::FLAG]). The ugEx27 array was crossed
into XB498 (kin-10(ok1751); glp-1(ar202gf)) to create XB637 (kin-10
(ok1751); glp-1(ar202gf); ugEx27).
T59–CTAGACCTAGGCTTATCGTCGTCACCTTGTAATCC
ATGGTGGCGGATCCCTGCA
T61–GGGATCCGCCACCATGGATTACAAGGATGACGACGATA
AGCCTAGGT
T56 – GAATTGGAGCTCCCGAAAAACACTGAAAATCG
T57 – TTTTTTCCTAGGAGTAGTTCGGAGGAGGTTTG
T54 – TTTAGTGGATCCGACTTCTGATCCAGACAAACTAG
T55 – TTCGATAAGCTTCTCGAGGATCTATTGATTTTCTTCTG
T10 – TTTTTTCTCGAGCTGAAAGAGATACTAATGTC
T11 – TTTTTTGGTACCTGAAAATATACTTTAATTTTTC
Intensity measurements
For western blot intensity measurements, autoradiographs were
scanned to electronic images in grayscale. Pixel intensity was mea-
sured by the “Analyze: Gels” function of ImageJ (NIH). For ﬂuorescent
intensity measurements, animals of different genotypes being com-
pared were mixed together and processed simultaneously for gonad
dissection, immunostaining and imaging. Strong KIN-10 expression in
the DTC and gonadal sheath cells were used to identify animals
containing the ugEx27[kin-10::FLAG] extrachromosomal array. To per-
form the measurement, the “Analyze: Measure” function of ImageJ
was used and the “Mean” intensity was used for the analysis.
Mosaic analysis
kin-10(ok1751); glp-1(ar202gf); ugEx27 animals were synchro-
nized at the L1 stage and allowed to develop to the young adult
stage. Animals were then dissected without screening, and gonad
dissection was performed as described above. Animals were
stained with DAPI, α-KIN-10 antibodies and α-HIM-3 antibodies,
and scored for germline phenotypes and KIN-10 distribution.
TBB treatment
Animals were grown in liquid culture with OP50 bacteria in M9
buffer. TBB (Calbiochem, Cat. no. 218708) was added to the culture
to the desired concentrations. Additional dimethyl sulfoxide
(DMSO) was added so that the amount of DMSO in the culture
was equal among different experimental conditions. L1 synchro-
nized animals of the corresponding genotype were then added to
the culture and grown at 15 1C to the young adult stage. To analyze
the phenotype, animals were harvested and scored under a
dissection microscope and veriﬁed using DIC microscopy.
Results
Identiﬁcation of new factors regulating the proliferative
fate vs. differentiation decision
The genetic pathway regulating the proliferative fate vs. differ-
entiation decision in the C. elegans germ line, downstream of GLP-
1/Notch signaling, includes signiﬁcant redundancy. Indeed, many
of the factors involved do not cause a signiﬁcant disruption in this
decision when their activity is removed, except in sensitized
genetic backgrounds (Hansen and Schedl, 2013). Therefore, certain
factors may not have yet been identiﬁed because of the lack of a
phenotype in previously utilized sensitized genetic backgrounds.
Additionally, many factors may not have yet been identiﬁed
through genetic means because of their involvement in other
processes, a disruption in which may mask a proliferative fate vs.
differentiation decision phenotype. Therefore, we devised a
genetic screen that could circumvent some of these limitations,
and potentially identify additional players in regulating the bal-
ance between germline proliferation and differentiation. We con-
ducted a genome-wide RNAi based genetic screen using the
Ahringer RNAi library (Kamath et al., 2003) and the rrf-1
(pk1417); gld-3(q730) double mutant as a sensitized genetic back-
ground. GLD-3 functions in the GLD-2 meiotic-entry pathway, and
a loss of GLD-3 does not signiﬁcantly disrupt the transition from
proliferation to differentiation (Eckmann et al., 2004), thereby
providing a sensitized background for observing a signiﬁcant
increase in the number of proliferative cells (over-proliferation)
in the germ line that has not previously been used for a large scale
screen. A second feature of this screen was the use of RNAi in the
rrf-1 mutant. In animals lacking rrf-1 activity, RNAi functions
properly in the germline; however, it functions poorly in many
somatic tissues (Kumsta and Hansen, 2012; Sijen et al., 2001).
Therefore, using rrf-1 allowed us to (1) focus on genes with
strong functions in the germ line as many somatic activities can
also inﬂuence germline proliferation, and (2) circumvent potential
deleterious phenotypes that impact somatic development, which
could prevent us from observing a germline phenotype.
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We systemically knocked down the expression of 15,200
genes (75% of genes) in the C. elegans genome through RNAi
using the feeding method (Timmons and Fire, 1998) and screened
for animals with a signiﬁcant increase in the number of prolif-
erative cells in the gonad and/or ectopic proliferation occurring in
the proximal end of the gonad (both referred to as an over-
proliferation phenotype) (Fig. S1). Given the redundancy between
the GLD-1 and GLD-2 pathways, and the tumor that is formed
when their functions are simultaneously reduced or eliminated
(Eckmann et al., 2004; Hansen et al., 2004b; Kadyk and Kimble,
1998), genes identiﬁed in this screen potentially function in the
GLD-1 pathway. However, reduction/elimination of either pathway
individually in a background with increased Notch signaling can
also result in over-proliferation (Hansen et al., 2004a); therefore,
genes identiﬁed in this screen could also potentially function as
negative regulators of Notch signaling.
In this screen we identiﬁed seven genes whose knockdown
results in over-proliferation in the rrf-1(pk1417); gld-3(q730) genetic
background (Figs. 2B and S1). As a proof of principle, we identiﬁed
genes that when mutated, are known or predicted to cause germline
over-proliferation when also mutant for gld-3(q730). For example, we
identiﬁed the known GLD-1 pathway component nos-3 (Hansen et
al., 2004b), and potential splicing factors lsm-4, Y65B4A.1 and mog-3
(Kasturi et al., 2010; Kerins et al., 2010). Even though we did identify
known components of the GLD-1 pathway, we did not identify all
genes that have previously been shown to be over-proliferative with
gld-3(q730), suggesting that our screen was not exhaustive or as
sensitive as we would have liked. For example, we did not identify
some of the 38 splicing factors that are known to cause over-
proliferation when their functions are reduced in a gld-3 mutant
background (Kerins et al., 2010). However, it should be noted that the
over-proliferation that is observed when splicing factor activity is
reduced in gld-3 mutants is often subtle, and can require dissection/
staining in order for over-proliferation to be properly scored, which
was not possible in our screen.
We also identiﬁed genes not previously described as having
phenotypes associated with over-proliferation in the C. elegans
germ line; namely, C27F2.10, tftc-3 and kin-10, none of which are
well characterized in C. elegans. Based on sequence similarity,
C27F2.10 is predicted to contain a PCI/PINT domain found in
regulatory components of the 26S proteasome and in a variety of
other proteins that are often parts of large protein complexes
(Ciccarelli et al., 2003). Its mammalian ortholog, PCI domain-
containing protein 2 (PCID2), has been implicated in B cell survival
by positively regulating MAD2 expression (Nakaya et al., 2010)
and is potentially involved in nuclear mRNA export through an
interaction with the mammalian TREX-2 (Transcription–export
complex 2) complex (Jani et al., 2012). tftc-3 is predicted to encode
a general transcription factor 3C subunit that functions as a
component of RNA polymerase III to transcribe rRNAs, tRNAs and
other small RNAs (Dieci et al., 2007). kin-10 encodes the regulatory
β subunit of protein kinase CK2, which is involved in a variety of
important cellular processes in many systems (Guerra and Issinger,
1999; Litchﬁeld, 2003); however, its function in C. elegans has not
been studied in detail. Here, we describe our characterization of
the role of kin-10 in the proliferative fate vs. differentiation
decision in the C. elegans germ line.
kin-10 single mutant displays a variety of mutant phenotypes
In order to understand how kin-10 could be involved in the
proliferative fate vs. differentiation decision, we ﬁrst analyzed its
single mutant phenotype. For this, we used the ok1751 allele,
which contains a 1452 bp deletion that spans almost the entire
kin-10 coding region, suggesting that it is a null allele of kin-10
(Fig. 2C). Additionally, KIN-10 protein cannot be detected in kin-10
(ok1751) animals by either western blot of whole-worm lysate or
immunostaining of dissected gonad arms (Fig. S2 and see below).
kin-10(ok1751) single mutant hermaphrodites display a range of
noticeable somatic and germline mutant phenotypes (Table 1).
While previous characterization of another kin-10 genetic mutant,
kin-10(tm1283) (Fig. 2C), was found to be lethal (Hu et al., 2006),
our more detailed analysis found that kin-10(ok1751) single
mutant hermaphrodites are smaller in size (Table 1) and die
within 2–3 days after passing the L4 stage. The majority (92%)
of kin-10 hermaphrodites also develop a protruding vulva with
6% displaying a multivulval phenotype (Table 1). However, the
development of kin-10(ok1751) animals is largely normal up to the
L4 stage. For example, their growth rate is similar to wild type; by
52 h, 90% of the animals (n¼100) have reached the L4 stage at
20 1C, after being released from the L1 arrest (compared to 48 h for
wild-type animals, n¼100). An adult germ line is developed in
these homozygous mutants, with normal germline polarity con-
sisting of a distal mitotic cell population and a proximal meiotic
cell population (Figs. 3C and S3). The germ line is Mog (Masculi-
nization of the Germ line), with excess sperm produced (250
sperm/gonad arm, n¼5), compared to wild-type animals, which
generate 150 sperm/gonad arm (Hirsh et al., 1976). Some
animals produce cells with a typical oocyte shape and appearance,
although they are somewhat smaller than wild-type oocytes (if the
animals live long enough), but no progeny are ever produced.
With respect to proliferation, the germ line is relatively small
compared to wild-type animals (Figs. 3 and S3), likely due to
Table 1
ugEx27 rescues kin-10(ok1751) mutant phenotypes.
Phenotypesa N2 kin-10(ok1751) kin-10(ok1751); ugEx27
Fertile, % (n)b 100 (98) 0 (98) 99 (98)
MZ, cell number (s.d.; n)c 205 (15; 15) 103 (16; 18) 204 (14; 5)
MZ, no. of M-phase cell (s.d.; n)d 3.3 (2.0; 36) 1.5 (1.8; 23) 2.5 (1.4; 20)
Pvl, % (n)e 0 (92) 92 (281) 0 (97)
Muv, % (n)e 0 (92) 6 (281) 0 (97)
Physical size, mm (s.d.; n)f 1126 (62; 14) 782 (63; 13) 1013 (35; 13)
a All analysis was performed on young adult animals grown at 20 1C.
b For kin-10(ok1751); ugEx27, it is expected that with increasing sample size, more animals are likely to be encountered with mosaic expression of the transgene in the
body, which could lead to infertility of the animal and slight decrease of the fertile percentage. However, animals with mosaic expression will remain quite rare.
c Average number of germ cells in the MZ, counted in dissected gonads stained with DAPI.
d Average number of positive α-phos-H3 germ cells in the MZ, counted in dissected gonads immunostained with α-phos-H3 antibodies.
e Pvl – protruding vulva; Muv – multivulva.
f Physical size was measured by taking a DIC image of the animal using a Zeiss Imager Z.1 microscope under 10 objective and measuring the length of the animal using
the “Measure: Length” function in AxioVision (Zeiss).
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reduced proliferative activity, with the number of cells within the
MZ 50% of wild-type (Table 1). Cells within the MZ remain
mitotically active, as evidenced by α-phos-H3 positive cells in the
MZ (Table 1). Therefore, wild-type kin-10 appears to have a role in
promoting robust proliferation in the germ line. We conﬁrmed
that these kin-10 single mutant phenotypes are due speciﬁcally to
a reduction/elimination of KIN-10 activity as all are rescued by a
kin-10(þ) transgene, ugEx27[kin-10::FLAG] (Table 1 and Fig. S3).
Fig. 3. kin-10(ok1751); gld-3(q730) tumorous germ line. Gonads of the (A) N2 (wild-type) animal, (B) gld-3(q730) single mutant and (C) kin-10(ok1751) single mutant display
normal germline polarity - a distal mitotic cell population (α-REC-8 positive cells) and a proximal meiotic cell population (α-HIM-3 positive cells). (D) Gonads of the kin-10
(ok1751); gld-3(q730) double mutant have a Pro phenotype. An ectopic proliferative cell population (ectopic α-REC-8 positive cells; arrowheads) can be found at the proximal
end of the gonad. (E, F) Gonad region of glp-1(q175) and kin-10(ok1751); glp-1(q175) animals shown by whole-mount DAPI. Without GLP-1/Notch activity, all germ cells pre-
maturely developed into sperm (arrowheads). Note, only some of the sperm are visible at the focal plane shown. Normal gonad morphology cannot be observed. Animals
were analyzed at the early L3 stage. Open arrows point to location of the future vulva. (G) Even though lacking GLP-1/Notch activity, the germ cells of the kin-10(ok1751); gld-
3(q730); glp-1(q175) triple mutant animals remain proliferative, as demonstrated by positive α-REC-8 staining. In all images, DAPI is used to mark cell nuclei. In (A)–(D) and
(G), gonads are outlined and an asterisk marks the distal end of the gonad. In (E) and (F), gonad morphology cannot be identiﬁed through DAPI staining. In (A)–(D), a thin
dash line marks the boundary between mitosis and meiosis. Scale bar¼50 μm.
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kin-10 inhibits the proliferative fate
In the RNAi screen described above we found that rrf-1
(pk1417); gld-3(q730); kin-10(RNAi) animals display a highly pene-
trant over-proliferation phenotype in adult animals (Figs. 2B and
S1), suggesting that kin-10 functions to inhibit the proliferative
fate in the germ line. By DIC microscopy, ectopic proliferative cells
at the proximal gonad (Pro) were observed in 60% (n¼258) of
the rrf-1(pk1417); gld-3(q730); kin-10(RNAi) animals, whereas only
2% (n¼404) of the rrf-1(pk1417); gld-3(q730) animals fed with
the control vector-only pL4440 bacteria are Pro (Fig. 2B). Consis-
tent with our RNAi results, 100% of kin-10(ok1751); gld-3(q730)
animals develop a Pro tumor (Fig. 3D). Further, immunostaining
analysis of dissected gonads using DAPI, α-REC-8 antibodies and
α-HIM-3 antibodies revealed that while the kin-10; gld-3 double
mutant develops a proximal germline tumor (Pro) (Fig. 3D), the
MZ of the kin-10(ok1751); gld-3(q730) germ line appears to be
somewhat smaller in size than wild-type (although larger than in
a kin-10 single mutant), and the border between the mitotic and
meiotic cells in the distal end appears similar to wild-type (Fig. 3D
and Table 2). Comparatively, no gld-3(q730) and kin-10(ok1751)
single mutant animals are Pro (Fig. 3B and Table 2).
The formation of the Pro tumor in kin-10; gld-3 double mutant
animals could be explained either by a defective proliferative fate
vs. differentiation decision, or by a failure of germ cells to properly
progress through meiosis, leading to a reversion back to the
mitotic cell cycle, similar to what is observed in a gld-1 single
mutant (Francis et al., 1995b). Indeed, kin-10(ok1751); gld-3(q730)
animals could have low levels of GLD-1, resulting in meiotic cells
reverting to the mitotic cell cycle. However, we found that GLD-1
levels are similar to wild-type in kin-10(ok1751); gld-3(q730)
animals (Fig. S4). To determine if kin-10 affects the proliferative
fate vs. differentiation decision, we investigated whether a loss of
kin-10 can enhance the over-proliferation phenotype of the weak
glp-1 gain-of-function (gf) alleles, glp-1(oz264gf) and glp-1
(ar202gf). These alleles provide sensitized backgrounds for over-
proliferation speciﬁcally due to a disruption in the proliferative
fate vs. differentiation decision (Hansen et al., 2004b). We found
that 100% of the kin-10(ok1751); glp-1(weak gf) double mutant
animals develop a robust germline tumor with both glp-1(gf)
alleles, suggesting that kin-10’s ability to enhance is not allele
speciﬁc (Fig. 4C and D). All kin-10(ok1751); glp-1(ar202gf) animals
grown at 20 1C develop a germline tumor with mitotically active
cells throughout the entire germ line as determined by DAPI, α-
REC-8, α-HIM-3 and α-phos-H3 staining (Fig. 4C and D). Most
gonad arms (85%; n¼80) show no sign of entry into meiosis at
either the L4 stage or the adult stage. All kin-10(ok1751) and glp-1
(ar202gf) single mutant animals do have entry into meiosis under
the same conditions (Figs. 3C and 4B). Additionally, kin-10; glp-1
(weak gf) double mutant animals grown at the permissive tem-
perature of 15 1C develop a distal over-proliferation phenotype,
which is often referred to as a late-onset tumor, with the MZ
greatly expanded as compared to either single mutant, and 20%
(n¼71) of the gonad arms develop a proximal tumor (Table 3).
That most kin-10(ok1751); glp-1(ar202gf) animals at 20 1C show no
evidence of meiotic entry, and that at 15 1C they display a late-
onset tumor, is consistent with these animals having a defect in
the proliferative fate vs. differentiation decision rather than
meiotic cells failing to progress through meiotic prophase and
returning to mitosis. Therefore, kin-10(þ) inhibits the proliferative
fate and/or promotes differentiation in the C. elegans germ line.
kin-10 likely functions in the GLD-1 pathway
The RNAi screen described above was designed to identify
genes involved in regulating the proliferative fate vs. differentia-
tion decision that were likely to function in the GLD-1 pathway by
promoting differentiation and/or inhibiting the proliferative fate.
However, these genes could instead inhibit GLP-1/Notch signaling.
To determine which of these two possibilities is most likely for
kin-10, we ﬁrst determined how kin-10 interacts with GLD-1 and
GLD-2 pathway genes (Table 2). As described earlier, genes in the
GLD-1 and GLD-2 pathways function redundantly. The mitosis-to-
meiosis transition occurs relatively normally when the activity of
one of the pathways is eliminated. However, if the activities of
both pathways are removed simultaneously, entry into meiosis is
severely disrupted, resulting in the development of a germline
tumor (Eckmann et al., 2004; Hansen et al., 2004b; Kadyk and
Kimble, 1998). We found that the proliferative fate vs. differentia-
tion decision was not disrupted when the activity of either gld-1 or
nos-3, the two components of the GLD-1 pathway, was eliminated
in the kin-10(ok1751) mutant animal (Table 2), suggesting that
Table 2
Interaction with components of the proliferative fate vs. differentiation pathway.
Genotype Phenotypea Average germ cells in MZ (S.D.; range)b nc
N2 Not Tum 205 (15; 181–236) 15
kin-10(ok1751) Not Tum 103 (16; 79–138) 18
gld-1(q485) Tumd 143 (11; 130–165) 15
gld-1(q485) male Not Tumd N.D. 430
gld-1(q485) kin-10(ok1751) Tumd 203 (42; 151–309) 15
gld-1(q485) kin-10(ok1751) male Not Tumd N.D. 430
gld-1(q485) kin-10(ok1751); glp-1(q175) Glp 0 430
nos-3(oz231) Not Tum 247 (7; 237–261) 15
kin-10(ok1751); nos-3(oz231) Not Tum 131 (9; 119–156) 15
gld-2(q497) Not Tum 362 (42; 303–451) 13
gld-2(q497) kin-10(ok1751) Not Tum 278 (36; 223–332) 15
gld-2(q497) kin-10(ok1751); glp-1(q175) Glp 0 430
gld-3(q730) Not Tum 336 (28; 298–385) 15
kin-10(ok1751); gld-3(q730) Tum 168 (13; 146–189) 15
kin-10(ok1751); gld-3(q730); glp-1(q175) Tum N.D. 430
a Phenotype refers only to the germline proliferation phenotype. Some mutants display other germline phenotypes that are not associated with the proliferative fate vs.
differentiation decision, and are not listed. Some mutants have slightly larger or smaller mitotic regions as compared to wild-type animals. Only mutants with ectopic
proliferative cells are labeled as “Tum”. Glp means that animals display a germline proliferation defect similar to glp-1() such that all germ cells prematurely differentiate
and no proliferative cells are present in the adult germ line. In all cases, n430 gonads were analyzed and 100% displayed the annotated general phenotype.
b N.D.¼has proliferative cells in the germ line, although the number was not determined.
c Sample size refers to the number of gonads counted.
d gld-1(q485) hermaphrodites develop tumorous germ lines due to defective meiotic progression, and not a defect in the proliferative fate vs. differentiation decision
(Francis et al., 1995b). Thus, gld-1(q485) males, which do not have a defect in meiotic progression, were used for the analysis.
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kin-10 does not function in the GLD-2 pathway. As already
mentioned, a loss of kin-10 led to a robust germline tumor with
gld-3(q730). Surprisingly, no germline over-proliferation was
observed in gld-2(q497) kin-10(ok1751) animals (Table 2), even
though gld-2 and gld-3 function in the same pathway. This
difference between gld-2(q497) kin-10(ok1751) and kin-10
(ok1751); gld-3(q730) is possibly due to gld-3 playing a more
signiﬁcant role in the GLD-2 pathway than gld-2, as has been
suggested elsewhere (Eckmann et al., 2004; Macdonald et al.,
2008; Mantina et al., 2009; Wang et al., 2012). If kin-10 functions
in the GLD-1 pathway, which is downstream of Notch signaling,
the tumor in kin-10(ok1751); gld-3(q730) animals should not be
dependent on Notch signaling. To test this, we removed GLP-1/
Notch activity from the kin-10(ok1751); gld-3(q730) double
mutant. kin-10(ok1751); gld-3(q730); glp-1(q175) triple mutant
animals still develop a germline tumor (Fig. 3G and Table 2),
consistent with kin-10 functioning downstream of GLP-1/Notch
signaling in the GLD-1 pathway. However, the over-proliferative
germ line of the kin-10; gld-3; glp-1 triple mutant (54.372.7
cell diameter, n¼7) is considerably smaller in size compared to
that of kin-10(ok1751); gld-3(q730) (78.974.1 rows of cells, n¼7)
(po0.0001), suggesting that even though glp-1(þ) is not required
for over-proliferation in kin-10(ok1751); gld-3(q730) animals, it
likely does contribute to over-proliferation in these double
mutants, and that kin-10 could also inhibit GLP-1/Notch signaling,
in addition to its proposed role in the GLD-1 pathway. Importantly,
that kin-10(ok1751); gld-3(q730); glp-1(q175) animals are tumor-
ous, rather than lacking proliferative cells as in a glp-1 single
mutant (Glp phenotype), suggests that the tumor in kin-10
(ok1751); gld-3(q730) double mutants is due to a defect in the
proliferative fate vs. differentiation decision rather than a re-entry
of meiotic cells into mitosis as in a gld-1 single mutant.
To further test the hypothesis that kin-10 primarily functions
downstream of GLP-1/Notch signaling, in the GLD-1 pathway, we
asked if kin-10(ok1751) could suppress the Glp phenotype of the
fbf-1 fbf-2 double mutant. FBF functions downstream of GLP-1/
Notch signaling and promotes the proliferative fate (Lamont et al.,
2004), in part, through down-regulating GLD-1 (Crittenden et al.,
2002). Removing fbf-1 and fbf-2 simultaneously in the germ line
leads to a Glp phenotype in adult animals, with no mitotic cell
population maintained in the germ line at 20 1C (Crittenden et al.,
2002). However, removal of gld-1 in the fbf-1 fbf-2 double mutant
suppresses the Glp phenotype, and reducing GLD-1 activity by half
is sufﬁcient to suppress the Glp phenotype and maintain a stable
MZ (Crittenden et al., 2002). Therefore, if kin-10 functions in the
GLD-1 pathway and a loss of kin-10 affects the activity of the GLD-
1 pathway, then kin-10(ok1751) should suppress the Glp pheno-
type of the fbf-1 fbf-2 double mutant. Indeed, kin-10(ok1751); fbf-1
(ok91) fbf-2(q704) triple mutant animals maintain a MZ in the
adult stage with noticeable mitotic activity, as indicated by the
presence of M-phase nuclei (Fig. S5).
Fig. 4. kin-10(ok1751) enhances glp-1(weak gf): (A) the N2 (wild-type) germ line. The gonad is stained with DAPI for germ cell nuclei, α-REC-8 (green) for mitotic cells and α-
HIM-3 (red) for meiotic cells. (B) In glp-1(weak gf) single mutant animals, the proliferative fate vs. differentiation decision is not severely disrupted at lower temperatures
(such as 20 1C), and the mitosis-to-meiosis transition occurs relatively normally. The gonad is stained with DAPI for germ cell nuclei, α-REC-8 for proliferative cells and α-
HIM-3 for meiotic cells. (C, D) When kin-10; glp-1(weak gf) double mutant animals are grown at 20 1C, the germ line develops an over-proliferation phenotype, with
mitotically active germ cells throughout the entire gonad. Gonads are stained with DAPI for germ cell nuclei, α-REC-8 for proliferative cells, α-HIM-3 for meiotic cells (no cell
is α-HIM-3 positive in (C)), and α-phos-H3 for M-phase cells. (E) An extrachromosomal array (ugEx27) containing a kin-10(þ) transgene rescues the kin-10(ok1751); glp-1
(weak gf) tumorous phenotype, showing distal proliferation (transition zone, arrowhead) and proximal differentiation (oocytes, arrows). Gonads are outlined and an asterisk
marks the distal end of each gonad. Scale bar¼50 μm.
Table 3
kin-10; glp-1(weak gf) mutant germline phenotypes at 15 1C.
Genotype Germline phenotype (%)a
WTMZ WTMZ
Pro
ExtendedMZ ExtendedMZ
Pro
Full
Tum
nb
N2 100 0 0 0 0 87
kin-10(ok1751) 100 0 0 0 0 97
glp-1(oz264gf) 93 7 0 0 0 108
kin-10(ok1751); glp-1
(oz264gf)
0 0 74 22 4 83
glp-1(ar202gf) 84 16 0 0 0 114
kin-10(ok1751); glp-1
(ar202gf)
0 0 71 23 6 71
a The MZ is annotated as WTMZ, if its size does not exceed the loop region, and
as ExtendedMZ, if the MZ expands past the loop region. The MZ of glp-1(weak gf)
alleles at 15 1C is often larger than that of the wild-type (N2), but it does not pass
the loop. Pro-Proximal tumor was also observed. Full Tum indicates that only
mitotic cells (no meiotic cells) were observed. The germline phenotypes were
identiﬁed by gonad dissection followed by immunostaining with α-REC-8 anti-
bodies and DAPI.
b Total number of dissected gonads analyzed.
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In addition to the GLD-1 and GLD-2 pathways that function
downstream of GLP-1/Notch signaling, we have previously pro-
posed the existence of a third pathway that functions in parallel to
the GLD-1 and GLD-2 pathways (Hansen et al., 2004a). Compo-
nents of this pathway are yet to be identiﬁed. The suggestion of a
third pathway is based, in part, on the gld-2 gld-1 double mutant
still having some cells that enter meiotic prophase, even though
the majority of cells remain proliferative (Hansen et al., 2004a).
It is possible that removal of the activity of any two pathways
could result in a tumor, and that kin-10 could function in the third
pathway. To test if kin-10 could be a novel component in the third
pathway we determined if a reduction in kin-10 activity could
enhance the over-proliferation phenotype produced by removing
components from both the GLD-1 and GLD-2 pathways. We found
that the gld-2(q497) kin-10(ok1751); nos-3(oz231) triple mutant
has the same level of meiotic entry as gld-2(q497); nos-3(oz231)
double mutants (Hansen et al., 2004a), with a meiotic region
greater than 20 rows of cells size (44713; n¼5). Therefore, kin-10
is unlikely to function in the third pathway.
kin-10 participates in other Notch mediated cell fate decisions
As mentioned above, kin-10’s primary function in the prolif-
erative fate vs. differentiation decision is likely to be executed in
the GLD-1 pathway. However, that kin-10(ok1751); gld-3(q730)
animals have more proliferation than when glp-1 activity is also
eliminated suggests that the tumor in kin-10(ok1751); gld-3(q730)
animals is not completely GLP-1/Notch signaling independent,
leaving open the possibility that kin-10 may also negatively
regulate Notch signaling. Indeed, CK2 has been shown to inhibit
Notch signaling in other systems (Cheng et al., 2013; Ranganathan
et al., 2011). We reasoned that if kin-10 inhibits GLP-1/Notch
signaling in the germ line, it might also inhibit Notch signaling
in other contexts. lin-12 encodes the second Notch receptor in C.
elegans and is involved in many cell fate decisions, including some
vulval cell fate decisions (Greenwald et al., 1983). In vulval
precursor cell (VPC) speciﬁcation, six VPCs are speciﬁed with one
of three different cell fates (11, 21 or 31) (Sternberg and Horvitz,
1986). LIN-12/Notch activity is involved in the lateral signaling that
speciﬁes the 21 VPC fate. 11 and 21 VPCs eventually divide and form
the vulva while 31 VPCs become non-vulval epidermal cells
(Sternberg and Horvitz, 1989). Elevated LIN-12/Notch activity
results in more than the normal number of cells with vulval cell
fates, generating a multiple pseudovulva phenotype (Muv) in adult
animals. We found that KIN-10 is expressed in the vulva (Fig. S6)
and kin-10(ok1751) enhances lin-12(weak gf) (Table 4). Therefore,
kin-10 is potentially involved in Notch regulated cell fate decisions
in both the germ line and the soma.
KIN-10 functions are mediated by the protein kinase CK2 holoenzyme
kin-10 encodes the β subunit of protein kinase CK2, which is a
tetrameric holoenzyme complex containing two α subunits and
two β subunits (Nieﬁnd et al., 2001) (Fig. 1D). The α subunit is the
catalytic subunit and supplies the kinase activity. The β subunit
is regulatory and is believed to enhance the stability, activity
and speciﬁcity of the α subunit (Bibby and Litchﬁeld, 2005;
Grankowski et al., 1991). CK2α and CK2β are traditionally con-
sidered to function together and exert functions only as a holoen-
zyme complex, but there is evidence that either subunit can exist
in free form and provide important holoenzyme-independent
functions (Bibby and Litchﬁeld, 2005; Dorr et al., 2008; Filhol et
al., 2003; Guerra et al., 2003; Kreutzer and Guerra, 2007; Yde et al.,
2008). To determine whether kin-10’s role in the proliferative
fate vs. differentiation decision is due to its function in the
CK2 holoenzyme, or if this role is carried out in a holoenzyme
independent manner, we sought to determine if the α subunit,
encoded by kin-3, is also involved in the proliferative fate vs.
differentiation decision.
kin-3 was not initially tested in our RNAi screen because it is
not included in the Ahringer library (Kamath et al., 2003). The
likely genetic null allele of kin-3, ok1516, results in animals
arresting at L3 stage, preventing us from analyzing adult germ-
line phenotypes. Therefore, we performed kin-3(RNAi), exposing
the animals to dsRNA at the L1 stage, which allowed the animals to
develop into adulthood. We found that, similar to kin-10(RNAi),
kin-3(RNAi) enhanced the over-proliferation phenotype of glp-1
(weak gf), as well as formed a Pro tumor with gld-3(q730) (Figs. 5
and S7). That both kin-3(RNAi) and kin-10(RNAi) enhance
over-proliferation in sensitized genetic backgrounds suggests that
it is the function of the CK2 holoenzyme, rather than a subunit
independent function, that helps to regulate the proliferative fate
in the C. elegans germ line.
However, one caveat to this conclusion is that reducing the level
of one subunit may cause the other subunit to become destabilized;
therefore, kin-3(RNAi) could enhance over-proliferation not by low-
ering CK2 activity, but rather by lowering KIN-10 levels, and that
KIN-10 may have a subunit independent function that is disturbed by
this lower level. Indeed, it has been shown in mammals (including
Table 4
kin-10(ok1751) enhances lin-12(weak gf) Muv phenotype.
Vulval protrusions (%)a
0 1 Z2 n
lin-12(n302gf) 76 18 6 298
kin-10(ok1751) 2 92 6 281
kin-10(ok1751); lin-12(n302gf) 3 67 30 355
a lin-12(n302gf) single mutant animals display a vulvaless phenotype (0 vulval
protrusions) (Greenwald et al., 1983), due to defective AC/VU cell fate speciﬁcation.
In lin-12(n302gf) animals, the AC cell is not properly speciﬁed because of elevated
Notch signaling, resulting in defective 11 VPC speciﬁcation. Meanwhile, constitutive
Notch activity is not strong enough to specify the 21 VPC; thus, no vulva is formed
in lin-12(n302gf) animals (Sundaram and Greenwald, 1993). However, with a low
level of constitutive Notch activity, lin-12(n302gf) can be used as a sensitized
background for increased 21 VPC formation.
Fig. 5. Both kin-3(RNAi) and kin-10(RNAi) enhance germline proliferation in
sensitized genetic backgrounds. Similar to kin-10(RNAi), kin-3(RNAi) enhances the
over-proliferation phenotype of glp-1(weak gf), and forms a Pro tumor with gld-3
(q730). All genetic mutants also contain the rrf-1(pk1417) mutation. pL4440 is the
vector-only negative control. RNAi on glp-1(weak gf) alleles was performed at 18 1C.
Sample animals were dissected and stained with DAPI and α-REC-8 to conﬁrm the
tumorous germline phenotype. ‘Tumorous’ animals have excess proliferative cells
in the germ line (may be in the distal and/or proximal (Pro) arm). n4100 for all
RNAi experiments.
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monkey COS-7, and human U-2 OS cells) that the CK2α subunit
phosphorylates CK2β and protects it from ubiquitin-mediated pro-
teasomal degradation (Zhang et al., 2002); elimination of the CK2α
subunit decreases the cellular level of the CK2β subunit (Yde et al.,
2008). We found that kin-3(RNAi) reduced the levels of KIN-10 to
35% of the wild-type levels (Fig. S2B). However, we consider it
unlikely that a reduction in KIN-10 to this level is enough to enhance
over-proliferation because ugEx27[kin-10::FLAG], which only
expresses KIN-10 at 25% of the wild-type levels in the distal germ
line, can rescue kin-10(ok1751); glp-1(ar202gf) over-proliferation
(Figs. 4E and S2C). However, to address the question of CK2
holoenzyme vs. KIN-10 subunit independent function further, we
interfered with the function of the CK2 holoenzyme through the use
of the TBB (4,5,6,7-tetrabromo-1H-benzotriazole) chemical inhibitor
of CK2, which has been used in other systems to down-regulate CK2
activity without compromising the level of CK2β (Pagano et al., 2008;
Yde et al., 2008). We found that at 15 1C TBB enhanced germline
over-proliferation in glp-1(ar202gf) animals as compared to the
DMSO control (Fig. 6). Therefore, the enhancement of germline
proliferation by reduction of KIN-10 and KIN-3 activity is most likely
due to a reduction of the CK2 holoenzyme function, rather than due
to a reduction in subunit independent functions.
KIN-10 acts in the germ line to inhibit the proliferative fate
Many factors in the pathway regulating the proliferative fate vs.
differentiation decision, including fbf-2, gld-1, gld-2, gld-3 and puf-
8, have non-uniform protein expression patterns in the germ line
that, in some cases, may help to explain the regulation of their
activities (Eckmann et al., 2002; Hansen et al., 2004b; Jones et al.,
1996; Lamont et al., 2004; Racher and Hansen, 2012; Wang et al.,
2002). To determine if KIN-10 levels differ spatially, we raised
antibodies against KIN-10. We found that KIN-10 is expressed
throughout the entire germ line with strong expression in the
cytoplasm and the nucleolus of the germ cells, and is also
expressed in the somatic gonad, including the DTC and somatic
sheath cells (Fig. 7). Strong KIN-10 expression is also found on the
centrosome during M-phase of mitotic cells (Fig. 7A), which likely
reﬂects a conserved function as centrosomal enrichment is also
observed in mammals (Faust et al., 2002; Krek et al., 1992).
Generally, no dramatic changes in expression are found between
cells with the proliferative fate, and those that have begun to
differentiate, suggesting that either CK2 function may be con-
trolled by some other mechanism, such as accessibility to relevant
target proteins, or that CK2 may function at a similar level
throughout the germ line, and control the level of a threshold
that other spatially controlled factors act upon.
Signals from the somatic gonad are essential for proper germ-
line proliferation. The DTC provides the signal for proliferation
(Austin and Kimble, 1987; Kimble and White, 1981), and ablation
of the sheath cells affects the amount of proliferation (McCarter et
al., 1997). Therefore, since KIN-10 is expressed in both the germ
line and the somatic gonad, it is possible that CK2 could function
in either of these tissues to inhibit the proliferative fate. To
determine in which tissue KIN-10 functions to inhibit the prolif-
erative fate, we performed mosaic analysis using kin-10(ok1751);
glp-1(ar202gf); ugEx27 animals (extrachromosomal arrays are
often imperfectly transmitted during cell division (Yochem and
Herman, 2005)). As mentioned earlier, the ugEx27[kin-10::FLAG]
array rescues both kin-10(ok1751) and kin-10(ok1751); glp-1
(ar202gf) mutant animals (Table 1 and Figs. 4E & S3). KIN-10
expressed from ugEx27 is found in the soma (e.g. intestine),
somatic gonad (DTC and gonadal sheath cells) and the germ line
(mitotic and meiotic germ cells). In mosaic gonads that have no
expression in the somatic gonad (including the DTC), expression in
the germline is sufﬁcient to suppress the tumorous phenotype of
the kin-10(ok1751); glp-1(ar202gf) double mutant (Table 5).
Although we did not recover animals with speciﬁc loss of the
ugEx27 array in the germ line, gonads with robust somatic gonad
KIN-10 expression, but very limited expression in the germ line,
maintain over-proliferation in regions where KIN-10 expression is
low or absent (Table 5). Therefore, KIN-10 likely acts in the germ
line to maintain the proper proliferative fate vs. differentiation
decision.
Discussion
CK2 is a Serine/Threonine protein kinase with involvement in
many known or predicted cellular functions (Alvarez et al., 2013;
Montenarh and Goẗz, 2013). By depleting C. elegans of KIN-10, the
β subunit of CK2, we ﬁnd that CK2 has important functions in
regulating sex determination, oogenesis, vulval development, and
the primary focus of this paper, the balance between the prolif-
erative fate and differentiation in the C. elegans germ line.
Although the single mutant of kin-10 demonstrates that CK2 is
required to maintain robust proliferation in the germ line, likely
due to its involvement in cell cycle progression, apoptosis and
potentially other important cellular activities, sensitized genetic
backgrounds reveal that CK2 also inhibits the proliferative fate in
the germ line. This activity functions, at least in part, downstream
of GLP-1/Notch signaling in the GLD-1 meiosis-promoting path-
way, to promote meiotic entry. The KIN-10 protein is expressed
throughout the germ line and somatic gonad; however, mosaic
analysis suggests that its role in regulating the proliferative fate vs.
differentiation decision is likely carried out by CK2 expressed in
the germ line. In the distal germ line, we propose that CK2
modulates the activity of its downstream target proteins, likely
through phosphorylation, which in turn execute a proper stem cell
fate transition from the proliferative fate to meiotic differentiation.
Fig. 6. Inhibition of CK2 by TBB enhances the over-proliferation of glp-1(weak gf).
TBB treatment on the wild-type (N2) animals does not affect KIN-10 protein level
and does not affect the germline proliferative fate vs. differentiation decision (A, B).
However, a tumorous germ line developed when treatment was performed on glp-
1(ar202gf) animals (C). All experiments were performed at 15 1C. In (A), tumorous
animals were scored using a dissecting microscope and randomly checked to
conﬁrm the phenotype using DIC microscopy. n4100 for all concentrations. In (B),
α-paramyosin (MH16) is used as a loading control. In (C), gonad is outlined and
asterisk marks the distal end of the gonad. Scale bar¼50 μm.
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C. elegans as a model to study CK2 function
CK2 is a highly conserved protein kinase that has over 300 known
or predicted targets (Cesaro and Salvi, 2013; Meggio and Pinna,
2003), and is involved in regulating many different cellular processes
(Montenarh and Goẗz, 2013). Most of our understanding of CK2
function has come from work using mammalian tissue culture
because depletion of CK2 activity in animals tends to create severe
early phenotypes, making it difﬁcult to study its roles in develop-
ment or in adult tissues. For example, knockouts of CK2 subunits in
mice leads to early embryonic lethality (Buchou et al., 2003; Seldin et
al., 2008), and tissue-speciﬁc conditional knockouts also result in
tissue proliferation defects (Buchou et al., 2003; Huillard et al., 2010).
Therefore, the functions of CK2 in certain tissues, such as the germ
line, are not well understood in any system. Here, we demonstrate
that C. elegans is a valuable model to study the role of CK2 in
development and tissue homeostasis because, unlike other more
complex organismal models, genetic mutants of CK2 grow past the
embryonic stage. Particularly, animals mutant for kin-10, which
encodes the β subunit, reach adulthood.
Fig. 7. KIN-10 expression in the germ line: (A) immunostaining of KIN-10 on N2 (wild-type) dissected gonads. KIN-10 is expressed throughout the entire gonad with strong
expression in the cytoplasm and the nucleolus of the germ cells. Insets: selective representations of KIN-10 expression in different parts of the gonad (KIN-10 is in green;
DNA is marked by DAPI, blue). Particularly, KIN-10 is localized to centrosomes during mitosis (“Mitotic cells” inset). TZ¼transition zone. (B) KIN-10 is enriched in the
nucleolus (marked by α-Nop1p). In both (A) and (B), the Apotome module (Zeiss) was used to reduce background ﬂuorescence. (C) Immunostaining using α-KIN-10
antibodies reveals minimum background staining on dissected kin-10(ok1751) gonads. In both (A) and (C), gonad is outlined and an asterisk marks the distal end of the
gonad. Scale bar¼50 μm.
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While there could be many reasons why kin-10 homozygous
null animals grow to adulthood, including relatively fast develop-
ment through embryogenesis and larval development in C. elegans,
a major factor likely is maternal contribution that provides CK2
function during early development. This assumption is due, in
part, to the more severe developmental phenotype observed in
kin-3 animals, suggesting that CK2 function is needed earlier in
development. A more severe phenotype in kin-3 mutants could be
due to less kin-3 product being provided maternally than kin-10
product, kin-10 product being more stable, or that the loss of the
kin-3 kinase subunit could have a greater impact on CK2 function.
Maternal contribution of CK2 allowing for post-embryonic devel-
opment is further supported by the more severe embryonic arrest
phenotype that is observed when kin-10 or kin-3 RNAi is per-
formed on the mother, rather than the offspring after L1 arrest,
presumably reducing maternal contribution (data not shown).
kin-10 single mutant animals display a variety of mutant
phenotypes, including misshapen oocytes and protruding vulva.
These mutants are also Mog, indicating that CK2 normally pro-
motes the female germline fate and/or inhibits the male fate. CK2
also has roles in various somatic developmental processes, as the
mutant animals display abnormal coloration, size and lifespan.
These many phenotypes suggest that CK2 is involved in various
developmental processes in C. elegans, and may interact with
different proteins/signaling pathways. Therefore, C. elegans is a
valuable model to study multiple functions of CK2.
CK2 likely phosphorylates many targets controlling the proliferative
fate vs. differentiation decision
The genetic pathway controlling the proliferative fate vs.
differentiation decision consists of a relatively linear pathway,
with the major regulator being the GLP-1/Notch signaling path-
way. The GLP-1/Notch pathway can be thought of as a switch, with
high levels of signaling resulting in proliferation, and low or absent
levels of signaling resulting in meiotic entry (Austin and Kimble,
1987; Berry et al., 1997). Whether this switch is ‘on’ or ‘off’
(or ‘high’ or ‘low’) dictates the activity of FBF, which, in part,
controls the activities of the GLD-1, GLD-2 and hypothetical third
pathways. The GLP-1/Notch signaling pathway functions as the
switch, dictating if cells are proliferative or meiotic, while the
genes downstream of the GLD-1, GLD-2 and third pathways are
likely those that execute this decision. Attempts to identify the
mRNA targets of GLD-1 have revealed hundreds of potential target
mRNAs (Jungkamp et al., 2011; Lee and Schedl, 2001; Ryder et al.,
2004; Scheckel et al., 2012; Wright et al., 2011). It is not surprising
that many genes would be involved in determining if a cell has a
proliferative or meiotic identity.
We have demonstrated that CK2 functions in the GLD-1 path-
way. GLD-1 functions primarily to inhibit translation; therefore, at
least some of its mRNA targets likely encode proteins necessary for
proliferation. Many of the known or predicted targets of
CK2 identiﬁed in other systems also have roles associated with
proliferation, including Cyclin H (Schneider et al., 2002), PTEN
(Torres and Pulido, 2001), p53 (Herrmann et al., 1991; Meek et al.,
1990), p21WAF1/CIP1 and p27KIP1(Gotz et al., 1996; Romero-Oliva
and Allende, 2001; Tapia et al., 2004), Topoisomerase II (Cardenas
et al., 1992), WEE1 (Yde et al., 2008) and many others. Therefore, it
is possible that CK2 and GLD-1 could interact with many of the
same targets. GLD-1 could inhibit the translation of these targets
as cells move more proximally, while CK2 could phosphorylate
and inhibit the activities of the proteins that were already
translated while the cells were in the mitotic zone, and persist
as the cells move more proximally. Of course, CK2 phosphorylation
could also activate targets that promote meiotic entry. Therefore,
CK2 could promote the switch from the proliferative fate to
meiosis by promoting the activities of proteins involved in meiosis
or differentiation.
CK2 both inhibits and promotes proliferation
In this study, we have demonstrated that animals only mutant
for kin-10 have smaller than normal germ lines, and a reduced
number of cells in the mitotic zone, suggesting that wild-type kin-
10 has a role in promoting robust proliferation in the germ line.
This is consistent with known functions of CK2 in other systems
with a reduced activity of CK2 being associated with a delay in cell
cycle progression (Kreutzer and Guerra, 2007; Yde et al., 2008), an
induction of apoptosis (Ahmad et al., 2008), and tissue atrophy
(Jauch et al., 2002). However, we have further demonstrated
that kin-10 and the CK2 holoenzyme also play a signiﬁcant role
in inhibiting the proliferative fate and/or promoting differentia-
tion. In sensitized genetic backgrounds, such as gld-3(q730) and
glp-1(gf), a reduction in CK2 activity results in signiﬁcant germline
over-proliferation. Therefore, our analysis suggests that CK2
functions both to promote robust proliferation, and inhibit the
proliferative fate.
The function of CK2 to promote cell proliferation is consistent
with a vast amount of evidence connecting CK2 to cancer. Up-
regulation of CK2 expression and activity are reported in many
human cancers, as well as in animal models of cancer (Seldin and
Landesman-Bollag, 2013). CK2 over-expression is also linked to
tumor aggressiveness (Giusiano et al., 2011), and CK2 has been
proposed to be a therapeutic target for cancer treatment, with
active clinical trials (Battistutta et al., 2011; Trembley et al., 2010).
However, no mutations in CK2 have been found in cancers,
suggesting that CK2 is unlikely to be an underlying cause of
cancer, but rather acts as a cooperating partner that contributes
to cancer development (Seldin and Landesman-Bollag, 2013).
Cancer development occurs in a variety of different cellular
contexts and involves complex cellular processes. With the large
number of veriﬁed and potential CK2 targets, it is possible
that a decrease of speciﬁc CK2 functions could also promote
tumor formation/development. Indeed, CK2β under-expression
has been reported in a subset of breast tumor samples, and
strongly correlates with the epithelial-to-mesenchymal transition,
Table 5
kin-10(ok1751); glp-1(ar202gf); ugEx27 mosaic analysis.
ugEx27 Expressiona Phenotypec nd
Intestine Somatic gonadb Germ line
þ þ þ Not Tum 668
þ  þ Not Tum 4
þ   Tum 3e
   Tum 2
a “þ” means that there is KIN-10 expression from the ugEx27 array; “” means
there is no KIN-10 expression. Animals with the following expression patterns were
not found: Intestine- Somatic gonadþ Germ lineþ; Intestine Somatic gonadþ
Germ line; Intestine Somatic gonad Germ lineþ; Intestineþ Somatic
gonadþ Germ line . Although we did not ﬁnd any gonads with a complete loss
of expression of ugEx27 speciﬁcally in the germ line, we did observe gonads with
low or absent expression at the distal part of the germ line. These gonads had a
signiﬁcantly enlarged MZ (the MZ is expanded close to or past the loop region).
b Includes gonadal sheath cells and DTC.
c Determined by DAPI and α-HIM-3 staining pattern in dissected gonads;
Not Tum – no ectopic proliferation and the MZ is not signiﬁcantly enlarged; Tum
– ectopic proliferative cells are observed and/or MZ is signiﬁcantly enlarged (the
MZ is expanded close to or past the loop region).
d Number of gonads.
e Two gonads (from different animals) have mosaic expression of KIN-10 in the
germ line, and these germ lines show a patchy Tum phenotype (clusters of mitotic
cells spread throughout the germ line), with KIN-10 negative germ cells also being
α-HIM-3 negative, suggesting that they have not entered meiotic prophase.
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enhancing the mobility and invasiveness of the tumor cells; thus
increasing the metastatic risk of the tumor (Deshiere et al., 2013).
Our ﬁndings suggest that the role of CK2 in regulating pro-
liferation may be quite complex. While a decrease in CK2 activity
reduces the amount of proliferation that occurs in the C. elegans
germ line, consistent with an increase in CK2 activity in certain
cancers, we demonstrate that CK2 also inhibits the proliferative
fate, as revealed in sensitized genetic backgrounds. Therefore, a
more complete understanding of CK2 function and its targets is
needed for its full involvement in regulating proliferation to be
understood, and before the implications of modulating its activity
to treat human disease can be accurately predicted. We have
identiﬁed the C. elegans germ line as a powerful model to pursue
our understanding of the role of CK2 function in controlling
proliferation.
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Montenarh, M., Goẗz, C., 2013. The interactome of protein kinase CK2. In: Pinna, L.A.
(Ed.), Protein Kinase CK2. John Wiley & Sons, Inc., Oxford, UK, pp. 76–116.
Morrison, D.K., 2012. MAP kinase pathways. Cold Spring Harb. Perspect. Biol. 1–4.
Nakaya, T., Kuwahara, K., Ohta, K., Kitabatake, M., Toda, T., Takeda, N., Tani, T.,
Kondo, E., Sakaguchi, N., 2010. Critical role of Pcid2 in B cell survival through
the regulation of MAD2 expression. J. Immunol. 185, 5180–5187.
Nieﬁnd, K., Guerra, B., Ermakowa, I., Issinger, O.G., 2001. Crystal structure of human
protein kinase CK2: insights into basic properties of the CK2 holoenzyme.
EMBO J. 20, 5320–5331.
Pagano, M.A., Bain, J., Kazimierczuk, Z., Sarno, S., Ruzzene, M., Di Maira, G., Elliott,
M., Orzeszko, A., Cozza, G., Meggio, F., Pinna, L.A., 2008. The selectivity of
inhibitors of protein kinase CK2: an update. Biochem. J. 415, 353–365.
Pasierbek, P., Jantsch, M., Melcher, M., Schleiffer, A., Schweizer, D., Loidl, J., 2001. A
Caenorhabditis elegans cohesion protein with functions in meiotic chromosome
pairing and disjunction. Genes Dev. 15, 1349–1360.
Pepper, A.S., Killian, D.J., Hubbard, E.J., 2003. Genetic analysis of Caenorhabditis
elegans glp-1 mutants suggests receptor interaction or competition. Genetics
163, 115–132.
Pezuk, J.A., Brassesco, M.S., Morales, A.G., de Oliveira, J.C., de Paula Queiroz, R.G.,
Machado, H.R., Carlotti Jr., C.G., Neder, L., Scrideli, C.A., Tone, L.G., 2013. Polo-like
kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to
cell death in glioblastoma. Cancer Gene Ther. 20, 499–506.
Racher, H., Hansen, D., 2012. PUF-8, a Pumilio homolog, inhibits the proliferative
fate in the Caenorhabditis elegans germline. G3 (Bethesda) 2, 1197–1205.
Rando, T.A., 2006. Stem cells, ageing and the quest for immortality. Nature 441,
1080–1086.
Ranganathan, P., Vasquez-Del Carpio, R., Kaplan, F.M., Wang, H., Gupta, A., VanWye,
J.D., Capobianco, A.J., 2011. Hierarchical phosphorylation within the ankyrin
repeat domain deﬁnes a phosphoregulatory loop that regulates Notch tran-
scriptional activity. J. Biol. Chem. 286, 28844–28857.
Reya, T., Morrison, S.J., Clarke, M.F., Weissman, I.L., 2001. Stem cells, cancer, and
cancer stem cells. Nature 414, 105–111.
Romero-Oliva, F., Allende, J.E., 2001. Protein p21(WAF1/CIP1) is phosphorylated by
protein kinase CK2 in vitro and interacts with the amino terminal end of the
CK2 beta subunit. J. Cell. Biochem. 81, 445–452.
Ryder, S.P., Frater, L.A., Abramovitz, D.L., Goodwin, E.B., Williamson, J.R., 2004. RNA
target speciﬁcity of the STAR/GSG domain post-transcriptional regulatory
protein GLD-1. Nat. Struct. Mol. Biol. 11, 20–28.
Scheckel, C., Gaidatzis, D., Wright, J.E., Ciosk, R., 2012. Genome-wide analysis of
GLD-1-mediated mRNA regulation suggests a role in mRNA storage. PLoS
Genet. 8, e1002742.
Schneider, E., Kartarius, S., Schuster, N., Montenarh, M., 2002. The cyclin H/cdk7/
Mat1 kinase activity is regulated by CK2 phosphorylation of cyclin H. Oncogene
21, 5031–5037.
X. Wang et al. / Developmental Biology 392 (2014) 26–4140
Seldin, D.C., Landesman-Bollag, E., 2013. The oncogenic potential of CK2. In: Pinna,
L.A. (Ed.), Protein Kinase CK2. John Wiley & Sons, Inc., Oxford, UK, pp. 292–304.
Seldin, D.C., Leder, P., 1995. Casein kinase II alpha transgene-induced murine
lymphoma: relation to theileriosis in cattle. Science 267, 894–897.
Seldin, D.C., Lou, D.Y., Toselli, P., Landesman-Bollag, E., Dominguez, I., 2008. Gene
targeting of CK2 catalytic subunits. Mol. Cell. Biochem. 316, 141–147.
Sijen, T., Fleenor, J., Simmer, F., Thijssen, K.L., Parrish, S., Timmons, L., Plasterk, R.H.,
Fire, A., 2001. On the role of RNA ampliﬁcation in dsRNA-triggered gene
silencing. Cell 107, 465–476.
Silva, H., Conboy, I.M., 2008. Aging and stem cell renewal. In: StemBook (Ed.),
StemBook. The Stem Cell Research Community, Cambridge, MA.
Stalter, G., Siemer, S., Becht, E., Ziegler, M., Remberger, K., Issinger, O.G., 1994.
Asymmetric expression of protein kinase CK2 subunits in human kidney
tumors. Biochem. Biophys. Res. Commun. 202, 141–147.
Sternberg, P.W., Horvitz, H.R., 1986. Pattern formation during vulval development
in C. elegans. Cell 44, 761–772.
Sternberg, P.W., Horvitz, H.R., 1989. The combined action of two intercellular
signaling pathways speciﬁes three cell fates during vulval induction in C.
elegans. Cell 58, 679–693.
Sundaram, M., Greenwald, I., 1993. Suppressors of a lin-12 hypomorph deﬁne genes
that interact with both lin-12 and glp-1 in Caenorhabditis elegans. Genetics 135,
765–783.
Tapia, J.C., Bolanos-Garcia, V.M., Sayed, M., Allende, C.C., Allende, J.E., 2004. Cell
cycle regulatory protein p27KIP1 is a substrate and interacts with the protein
kinase CK2. J. Cell. Biochem. 91, 865–879.
Tax, F.E., Yeargers, J.J., Thomas, J.H., 1994. Sequence of C. elegans lag-2 reveals a cell-
signalling domain shared with Delta and Serrate of Drosophila. Nature 368,
150–154.
Thornburg, W., Lindell, T.J., 1977. Puriﬁcation of rat liver nuclear protein kinase NII.
J. Biol. Chem. 252, 6660–6665.
Timmons, L., Fire, A., 1998. Speciﬁc interference by ingested dsRNA. Nature 395,
854.
Torres, J., Pulido, R., 2001. The tumor suppressor PTEN is phosphorylated by the
protein kinase CK2 at its C terminus. Implications for PTEN stability to
proteasome-mediated degradation. J. Biol. Chem. 276, 993–998.
Trembley, J.H., Chen, Z., Unger, G., Slaton, J., Kren, B.T., Van Waes, C., Ahmed, K.,
2010. Emergence of protein kinase CK2 as a key target in cancer therapy.
Biofactors 36, 187–195.
Wang, C., Wilson-Berry, L., Schedl, T., Hansen, D., 2012. TEG-1 CD2BP2 regulates
stem cell proliferation and sex determination in the C. elegans germ line and
physically interacts with the UAF-1 U2AF65 splicing factor. Dev. Dyn. 241,
505–521.
Wang, L., Eckmann, C.R., Kadyk, L.C., Wickens, M., Kimble, J., 2002. A regulatory
cytoplasmic poly(A) polymerase in Caenorhabditis elegans. Nature 419, 312–316.
Wright, J.E., Gaidatzis, D., Senften, M., Farley, B.M., Westhof, E., Ryder, S.P., Ciosk, R.,
2011. A quantitative RNA code for mRNA target selection by the germline fate
determinant GLD-1. EMBO J. 30, 533–545.
Yde, C.W., Olsen, B.B., Meek, D., Watanabe, N., Guerra, B., 2008. The regulatory beta-
subunit of protein kinase CK2 regulates cell-cycle progression at the onset of
mitosis. Oncogene 27, 4986–4997.
Yenice, S., Davis, A.T., Goueli, S.A., Akdas, A., Limas, C., Ahmed, K., 1994. Nuclear
casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and
cancerous prostate. Prostate 24, 11–16.
Yochem, J., Greenwald, I., 1989. glp-1 and lin-12, genes implicated in distinct cell–
cell interactions in C. elegans, encode similar transmembrane proteins. Cell 58,
553–563.
Yochem, J., Herman, R.K., 2005. Genetic mosaics. The C. elegans Research Community.
WormBook, http://dx.doi.org/10.1895/wormbook.1.58.1, /http://www.wormbook.
orgS.
Yu, F.X., Zhang, Y., Park, H.W., Jewell, J.L., Chen, Q., Deng, Y., Pan, D., Taylor, S.S., Lai,
Z.C., Guan, K.L., 2013. Protein kinase A activates the Hippo pathway to modulate
cell proliferation and differentiation. Genes Dev. 27, 1223–1232.
Zetka, M.C., Kawasaki, I., Strome, S., Muller, F., 1999. Synapsis and chiasma formation in
Caenorhabditis elegans require HIM-3, a meiotic chromosome core component that
functions in chromosome segregation. Genes Dev. 13, 2258–2270.
Zhang, C., Vilk, G., Canton, D.A., Litchﬁeld, D.W., 2002. Phosphorylation regulates
the stability of the regulatory CK2beta subunit. Oncogene 21, 3754–3764.
X. Wang et al. / Developmental Biology 392 (2014) 26–41 41
